Gregory Judy, MD
Radiation Oncology · Richmond, VANPI 1366881807
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Novocure Inc. at 29.0% of the total.
Across 39 payments — averaging $24.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$281
- Astellas Pharma US Inc$142
- Siemens Medical Solutions USA, Inc.$117
- Progenics Pharmaceuticals, Inc.$92
- Bayer$59
- Isoray, Inc$55
- plus $223 from 10 others
What the payments were for
- Food & beverage$969100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 8 | $281 |
| Astellas Pharma US Inc | 8 | $142 |
| Siemens Medical Solutions USA, Inc. | 1 | $117 |
| Progenics Pharmaceuticals, Inc. | 5 | $92 |
| Bayer | 3 | $59 |
| Isoray, Inc | 2 | $55 |
| Blue Earth Diagnostics | 2 | $51 |
| Boston Scientific | 2 | $28 |
| AstraZeneca | 1 | $25 |
| Pfizer | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Cardinal Health 414 LLC | 1 | $19 |
| Varian Medical Systems, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Rochester Medical Corporation | 1 | $15 |
| Myovant Sciences Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$969 in reported general payments places this provider in the 70th percentile of 121 radiation oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 225 | $2,370 |
| Oxybutynin Chloride ErOxybutynin Chloride | 108 | $2,064 |
| Dicyclomine Hcl | 18 | $155 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $149 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Richmond
- Joseph PenningtonRichmond$6K
- Timothy HarrisRichmond$3K
- Elisabeth WeissRichmond$3K
- Judy ChinRichmond$1K
- Lang LiebmanRichmond$957
- Laurie CuttinoRichmond$883
- Christopher ChipkoRichmond$862
- Rebecca KrcRichmond$777
- Bernard TisdaleRichmond$725
- David RandolphRichmond$693
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.